(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.47%) $78.48
(0.33%) $2.15
(0.36%) $2 317.00
(1.59%) $27.12
(-0.48%) $960.65
(0.02%) $0.929
(-0.17%) $10.86
(-0.01%) $0.797
(0.00%) $91.45
Live Chart Being Loaded With Signals
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export...
Stats | |
---|---|
本日の出来高 | 216 352 |
平均出来高 | 846 169 |
時価総額 | 3.78M |
EPS | £0 ( 2021-05-05 ) |
Last Dividend | £0.800 ( 2011-04-06 ) |
Next Dividend | £0 ( N/A ) |
P/E | 0 |
ATR14 | £0.0550 (3.44%) |
IQ-AI Ltd 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
IQ-AI Ltd 財務諸表
Annual | 2022 |
収益: | £535 886 |
総利益: | £534 104 (99.67 %) |
EPS: | £-0.00290 |
FY | 2022 |
収益: | £535 886 |
総利益: | £534 104 (99.67 %) |
EPS: | £-0.00290 |
FY | 2021 |
収益: | £521 069 |
総利益: | £504 022 (96.73 %) |
EPS: | £-0.00339 |
FY | 2020 |
収益: | £255 314 |
総利益: | £246 767 (96.65 %) |
EPS: | £-0.00480 |
Financial Reports:
No articles found.
IQ-AI Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £1.303 | 1994-02-28 |
Last Dividend | £0.800 | 2011-04-06 |
Next Dividend | £0 | N/A |
Payout Date | 2011-05-05 | |
Next Payout Date | N/A | |
# dividends | 31 | -- |
Total Paid Out | £98.61 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.81 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
1994 | £0 | 0.00% |
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TPK.L | Dividend Knight | 2023-10-05 | Annually | 32 | 1.73% | |
LWI.L | Dividend King | 2023-06-29 | Quarterly | 53 | 2.58% | |
CPG.L | Dividend Knight | 2023-06-08 | Annually | 24 | 0.87% | |
RTO.L | Dividend Knight | 2023-08-03 | Annually | 32 | 0.88% | |
HILS.L | Dividend King | 2023-11-30 | Semi-Annually | 32 | 1.26% | |
AXI.L | Dividend Knight | 2023-08-03 | Quarterly | 9 | 4.00% | |
VP.L | Dividend Knight | 2023-06-22 | Annually | 33 | 2.60% | |
MSLH.L | Dividend Knight | 2023-10-19 | Annually | 33 | 1.56% | |
DNLM.L | Dividend King | 2023-10-26 | Semi-Annually | 18 | 3.31% | |
SKG.L | Dividend King | 2023-09-28 | Semi-Annually | 17 | 2.40% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.855 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.432 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.857 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.638 | 0.800 | -1.812 | -1.450 | [1 - 3] |
quickRatioTTM | 0.638 | 0.800 | -0.956 | -0.765 | [0.8 - 2.5] |
cashRatioTTM | 0.129 | 1.500 | -0.394 | -0.591 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -43.96 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.00142 | 2.00 | -0.000472 | -0.000944 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00145 | 2.00 | -0.000724 | -0.00145 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.764 | 1.000 | 0.604 | 0.604 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.836 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.505 | 0.800 | 9.97 | 7.97 | [0.5 - 2] |
Total Score | -4.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.90 | 1.000 | -0.697 | 0 | [1 - 100] |
returnOnEquityTTM | -0.857 | 2.50 | -6.84 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00145 | 2.00 | -0.000483 | -0.00145 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.00142 | 2.00 | -0.000472 | -0.000944 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 31.48 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.460 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -1.070 |
IQ-AI Ltd
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。